Earlier testing for pancreatic and ovarian cancer

Researchers have identified RNA molecules that could lead to a simple blood test to detect aggressive cancers like pancreatic and ovarian at an earlier stage. These cancers have low survival rates because they are difficult to diagnose, particularly in the early stages. Associate Professor Jason Lee discusses developing a drug that could stop aggressive cancer cells from growing and spreading to other areas. Right now, he is testing the blood samples of people with severe and early stage pancreatic cancer and those who are healthy to find out how early the disease can be detected. This gives real hope that there could be earlier diagnosis and a novel drug to disarm aggressive tumour cells.